Correction to: Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study

被引：0
|
作者：
Rita Del Pinto
Corrado Giua
Enrico Keber
Eleonora Grippa
Marco Tilotta
Claudio Ferri
机构：
[1] University of L’Aquila,Department of Clinical Medicine, Public Health, Life and Environmental Sciences
[2] San Salvatore Hospital,Internal Medicine and Nephrology Unit, ESH Excellence Center for Hypertension and Cardiovascular Prevention
[3] Case Western Reserve University,Department of Pathology, School of Medicine
[4] Società Italiana Farmacia Clinica (SIFAC),undefined
[5] Medical Affairs,undefined
[6] Servier Italia,undefined
来源：
High Blood Pressure & Cardiovascular Prevention | 2023年 / 30卷 / 5期
关键词：
D O I：
10.1007/s40292-023-00599-w
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 487
相关论文
共 50 条
  • [31] CONTROL OF CARDIOVASCULAR RISK FACTORS ACCORDING TO SCORE SYSTEM IN HYPERTENSIVE PATIENTS: ESC/EAS 2016 AND 2019 DYSLIPIDEMIA GUIDELINES COMPARISON
    Sarzani, R.
    Falzetti, S.
    Giulietti, F.
    Di Pentima, C.
    Ristori, L.
    Buscarini, S.
    Spannella, F.
    ATHEROSCLEROSIS, 2020, 315 : E177 - E178
  • [32] A STUDY OF PHARMACEUTICAL CARE IMPACT ON CARDIOVASCULAR RISK IN DIABETIC AND HYPERTENSIVE PATIENTS
    Chander, J. Sam Johnson Udaya
    Prakasam, Arul
    Kannan, Subramaniam
    Kumar, Senthil
    Tyagi, Manoj G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (08): : 3135 - 3141
  • [33] The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease
    van Kruijsdijk, Rob C. M.
    van der Graaf, Yolanda
    Algra, Ale
    de Borst, Gert Jan
    Cramer, Maarten J.
    Siersema, Peter D.
    Peeters, Petra H. M.
    Visseren, Frank L. J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) : 2588 - 2589
  • [34] The underestimated impact of smoking and smoking cessation on the risk of secondary cardiovascular disease events in patients with stable coronary heart disease:: Prospective cohort study
    Twardella, D
    Rothenbacher, D
    Hahmann, H
    Wüsten, B
    Brenner, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 887 - 889
  • [35] STONE study and INSIGHT study: Efficacy of nifedipine in the prevention of cardiovascular disease in hypertensive patients
    Matsuoaka, Hiroaki
    DRUGS, 2006, 66 : 13 - 15
  • [36] A Cross-Sectional Study of Risk Factors for Coronary Heart Disease in Secondary Prevention for Patients With the Disease in China
    Shen, Qianqian
    Wu, Yiyuan
    Zhou, Ying
    Yang, Na
    Yu, Juping
    Ouyang, Xinping
    He, Pingping
    JOURNAL OF CLINICAL NURSING, 2024,
  • [37] GUIDELINES Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance
    Rabar, Silvia
    Harker, Martin
    O'Flynn, Norma
    Wierzbicki, Anthony S.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [38] Impact of guidelines of the management of cardiovascular risk factors in diabetic patients with macrovascular disease
    Kollias, A.
    Xilomenos, A.
    Ikonomopoulou, K.
    Tolis, A.
    INTERNATIONAL ANGIOLOGY, 2010, 29 (01) : 87 - 88
  • [39] Guidelines - Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance
    Cooper, Angela
    O'Flynn, Norma
    BRITISH MEDICAL JOURNAL, 2008, 336 (7655): : 1246 - 1248
  • [40] Adherence to the 2021 dietary guidelines of the European Society of Cardiology on cardiovascular disease prevention in residents of the Pomeranian Voivodeship with increased cardiovascular risk
    Dardzinska, Jolanta A.
    Malgorzewicz, Sylwia
    Szupryczynska, Natalia
    Gladys, Katarzyna
    Sliwinska, Aleksandra
    Kaczkan, Malgorzata
    Pieszko, Magdalena
    Wojda, Anna
    Wernio, Edyta
    Gogga, Patrycja
    Janczy, Agata
    Rzyman, Witold
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (06):
12345